Get a Full-Body Workout at Home With This 5-in-1 Excercise Bike for Just $163
Upright cycling, rowing, strength training — all from one foldable machine.
The Download: cut through AI coding hype, and biotech trends to watch
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. AI coding is now everywhere. But not everyone is convinced. Depending who you ask, AI-powered coding is either giving software developers an unprecedented productivity boost or churning out masses of poorly designed code…
TopTechTrends
X restricts Grok’s image generation to paying subscribers only after drawing the world’s ire
Elon Musk’s AI company has restricted Grok’s controversial AI image-generation feature to only paying subscribers on X, after the tool invited heated criticism from across the world for letting users generate sexualized images of women and children.
The Download: the case for AI slop, and helping CRISPR fulfill its promise
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. How I learned to stop worrying and love AI slop —Caiwei Chen If I were to locate the moment AI slop broke through into popular consciousness, I’d pick the video of rabbits bouncing…
There’s a Looming Threat in the Workplace — and It’s Keeping Everyone on Edge. Here’s How to Face It Head On.
Positions that were once seen as indispensable are now obsolete thanks to this threat, and team members are watching leadership to see if, when and how their job will be next.
The venture firm that ate Silicon Valley just raised another $15 billion
In a blog post published Friday morning, Ben Horowitz writes that “as the American leader in Venture Capital, the fate of new technology in the United States rests partly on our shoulders.” It’s the kind of statement certain to cause agita at rival firms.
A new CRISPR startup is betting regulators will ease up on gene-editing
Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest biotech breakthrough of the century. Yet so far, there’s been only one gene-editing drug approved. It’s been used commercially on only about 40 patients, all with sickle-cell disease. It’s becoming clear that the impact of CRISPR…
Anthropic adds Allianz to growing list of enterprise wins
Anthropic announces its first enterprise deal of 2026 which includes building agents and for, and giving Claude code, to Allianz.
Data security startup Cyera hits $9B valuation six months after being valued at $6B
Cyera raised another $400 million just six months after its last huge round.
Governments grapple with the flood of non-consensual nudity on X
For the past two weeks, X has been flooded with AI manipulated nude images, created by the Grok AI chatbot — and governments around the world are promising to take action.
GTMfund has rewritten the distribution playbook for the AI era
Building software products has never been easier, so why are so many well-funded startups failing to take off no matter how good their product is? In this season finale episode of Build Mode, our guest has an answer: Startups have focused too much on product development and not enough on distribution excellence. Paul Irving is partner and […]